Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli

被引:96
作者
Morrow, JA
Arnold, KS
Weisgraber, KH
机构
[1] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA
[2] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94141 USA
[3] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94141 USA
关键词
D O I
10.1006/prep.1999.1069
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein (apo) E plays an important role in lipid metabolism, and the major isoforms of apoE (apoE2, apoE3, and apoE4) have significantly different metabolic effects. Apolipoprotein E4 is associated with a higher risk of both heart disease and Alzheimer's disease (AD), Patients homozygous for apolipoprotein E2 are predisposed to type III hyperlipoproteinemia, and apoE2 may be protective against AD. Structure/function studies have proved to be a useful tool in understanding how the different apoE isoforms result in different pathological consequences. As these studies continue, it is essential to have a reliable method to produce large quantities of apoE and mutants of apoE. We describe here a method of apoE production in Escherichia coli strain BL21(DE3), The cDNA from apoE isoforms was inserted into a pET32a vector with a T7 promoter and a fusion partner (thioredoxin). The T7 promoter results in high expression of an easily purified His-tagged fusion protein. A thrombin recognition site was positioned in the expression vector so that only two novel amino acids (Gly-Ser) are added to the amino terminus of apoE following the removal of thioredoxin. Approximately 20 mg of apoE is obtained from a l-liter culture. The major isoforms of apoE produced with this system were extensively characterized for their ability to bind the low-density lipoprotein (LDL) receptor, for their characteristic lipid association preferences, and for their stability as measured by guanidine denaturation. The recombinant proteins behaved identically to plasma-derived apoE isoforms. (C) 1999 Academic Press.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 42 条
  • [1] AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249
  • [2] ARNOLD KS, 1992, LIPOPROTEIN ANAL PRA, P145
  • [3] METABOLISM OF VERY LOW-DENSITY LIPOPROTEIN PROTEINS .1. PRELIMINARY IN-VITRO AND IN-VIVO OBSERVATIONS
    BILHEIMER, DW
    LEVY, RI
    EISENBERG, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (02) : 212 - +
  • [4] LABELING OF PROTEINS TO HIGH SPECIFIC RADIOACTIVITIES BY CONJUGATION TO A I-125-CONTAINING ACYLATING AGENT - APPLICATION TO RADIOIMMUNOASSAY
    BOLTON, AE
    HUNTER, WM
    [J]. BIOCHEMICAL JOURNAL, 1973, 133 (03) : 529 - 538
  • [5] APOLIPOPROTEIN-E DEGRADATION IN HUMAN VERY LOW-DENSITY LIPOPROTEINS BY PLASMA PROTEASE(S) - CHEMICAL AND BIOLOGICAL CONSEQUENCES
    BRADLEY, WA
    GILLIAM, EB
    GOTTO, AM
    GIANTURCO, SH
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 109 (04) : 1360 - 1367
  • [6] Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide A beta
    Chan, W
    Fornwald, J
    Brawner, M
    Wetzel, R
    [J]. BIOCHEMISTRY, 1996, 35 (22) : 7123 - 7130
  • [7] PROTECTIVE EFFECT OF APOLIPOPROTEIN-E TYPE-2 ALLELE FOR LATE-ONSET ALZHEIMER-DISEASE
    CORDER, EH
    SAUNDERS, AM
    RISCH, NJ
    STRITTMATTER, WJ
    SCHMECHEL, DE
    GASKELL, PC
    RIMMLER, JB
    LOCKE, PA
    CONNEALLY, PM
    SCHMADER, KE
    SMALL, GW
    ROSES, AD
    HAINES, JL
    PERICAKVANCE, MA
    [J]. NATURE GENETICS, 1994, 7 (02) : 180 - 184
  • [8] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES
    CORDER, EH
    SAUNDERS, AM
    STRITTMATTER, WJ
    SCHMECHEL, DE
    GASKELL, PC
    SMALL, GW
    ROSES, AD
    HAINES, JL
    PERICAKVANCE, MA
    [J]. SCIENCE, 1993, 261 (5123) : 921 - 923
  • [9] APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS
    DAVIGNON, J
    GREGG, RE
    SING, CF
    [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 1 - 21
  • [10] DONG LM, 1994, J BIOL CHEM, V269, P22358